Journal of developmental and behavioral pediatrics : JDBP · 2012
Longitudinal study of emerging mental health concerns in youth perinatally infected with HIV and peer comparisons.
Сравнительное исследованиеСтатьяПоддержка NIH: внешняя программаНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Gadow Kenneth D, Angelidou Konstantia, Chernoff Miriam, Williams Paige L, Heston Jerry, Hodge Janice, Nachman Sharon
Аннотация
OBJECTIVE: Cross-sectional research indicates high rates of mental health concerns among youth with perinatal HIV infection (PHIV), but few studies have examined emerging psychiatric symptoms over time.
METHODS: Youth with PHIV and peer comparisons who were HIV-exposed but uninfected or living in households with HIV-infected family members (HIV-affected) and primary caregivers participated in a prospective, multisite, longitudinal cohort study. Groups were compared for differences in the incidence of emerging psychiatric symptoms during 2 years of follow-up and for differences in psychotropic drug therapy. Logistic regression models were used to evaluate the association of emerging symptoms with HIV status and psychosocial risk factors.
RESULTS: Of 573 youth with study entry assessments, 92% attended at least 1 annual follow-up visit (PHIV: 296; comparisons: 229). A substantial percentage of youth who did not meet symptom criteria for a psychiatric disorder at study entry did so during follow-up (PHIV = 36%; comparisons = 42%). In addition, those who met criteria at study entry often met criteria during follow-up (PHIV = 41%; comparisons = 43%). Asymptomatic youth with PHIV were significantly more likely to receive psychotropic medication during follow-up than comparisons. Youth with greater HIV disease severity (entry CD4% <25% vs 25% or more) had higher probability of depression symptoms (19% vs 8%, respectively).
CONCLUSIONS: Many youth in families affected by HIV are at risk for development of psychiatric symptoms.
METHODS: Youth with PHIV and peer comparisons who were HIV-exposed but uninfected or living in households with HIV-infected family members (HIV-affected) and primary caregivers participated in a prospective, multisite, longitudinal cohort study. Groups were compared for differences in the incidence of emerging psychiatric symptoms during 2 years of follow-up and for differences in psychotropic drug therapy. Logistic regression models were used to evaluate the association of emerging symptoms with HIV status and psychosocial risk factors.
RESULTS: Of 573 youth with study entry assessments, 92% attended at least 1 annual follow-up visit (PHIV: 296; comparisons: 229). A substantial percentage of youth who did not meet symptom criteria for a psychiatric disorder at study entry did so during follow-up (PHIV = 36%; comparisons = 42%). In addition, those who met criteria at study entry often met criteria during follow-up (PHIV = 41%; comparisons = 43%). Asymptomatic youth with PHIV were significantly more likely to receive psychotropic medication during follow-up than comparisons. Youth with greater HIV disease severity (entry CD4% <25% vs 25% or more) had higher probability of depression symptoms (19% vs 8%, respectively).
CONCLUSIONS: Many youth in families affected by HIV are at risk for development of psychiatric symptoms.
Предметные рубрики MeSH
AdolescentAnti-HIV AgentsAnxiety, SeparationAttention Deficit Disorder with HyperactivityAttention Deficit and Disruptive Behavior DisordersAttitude to HealthCase-Control StudiesChildChild of Impaired ParentsCross-Sectional StudiesMajor Depressive DisorderDrug UtilizationFemaleHIV InfectionsHIV SeropositivityHumansIncidenceInfectious Disease Transmission, VerticalLongitudinal StudiesMaleMental DisordersPeer GroupPersonality AssessmentPsychometricsPsychotropic DrugsSocial EnvironmentSocial StigmaViral Load